Table of contents
December 2005 Volume 2 No 12
Top of page
Editorial
Top of pageUse of
579
Research Highlights
Postoperative prognostic prediction models for nonmetastatic RCC
578Tumor multifocality is associated with worse outcome in prostate cancer
578Predicting mortality after hormonal therapy for postsurgical or postradiologic PSA failure
579Use of 
-blocker therapy for dysfunctional voiding in children
579Noninvasive measurement of bladder obstruction in men
580Improved clinical outcome in prostate cancer: real or statistical artefact?
580A third of phase I oncology trials remain unreported
580Enuresis alarm alone as effective as alarm with drugs
582Efficacy of prophylactic levofloxacin in cancer patients with neutropenia
582Top of page
Practice Points
Can we preoperatively identify men who are at high risk for aggressive prostate cancer?
584Is carboplatin as effective as radiotherapy for the adjuvant treatment of stage I seminoma?
586Does lymphadenectomy improve cancer-specific survival in patients with renal cell carcinoma?
588High-dose chemotherapy in germ-cell cancer salvage regimens: where next?
590What are the survival outcomes for prostate cancer in a population-based cohort of unscreened men?
592Top of page
Reviews
Angiogenesis imaging in the management of prostate cancer
596doi:10.1038/ncpuro0356 | Full Text | PDF (1,123K)
Therapy Insight: osteoporosis during hormone therapy for prostate cancer
608doi:10.1038/ncpuro0326 | Full Text | PDF (133K)
Mechanisms of Disease: normal and abnormal gonadal development and sex determination in mammals
616doi:10.1038/ncpuro0354 | Full Text | PDF (212K)
